SPARC : LITIGATION SETTLED; COMPANY ENTITLED TO REFUND OF RS 27.51 CR

• Tribunal upheld the Order-in-Appeal dated 27.04.2018 in favour of the Company. • Company entitled to refund of accumulated CENVAT credit along with consequential interest of ₹27.51 Cr. • Revenue's appeal dismissed, litigation stands decided in favour of the Company.

Sun Pharma Advanced Research Company Ltd

Open attachment

← Back to feed